Developing an Opioid Taper Intervention Before Total Joint Arthroplasty

Recruiting N/A Interventional Study
Arthritis Knee Arthritis Hip Chronic Pain
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
45 (estimated)
Sponsor
University of Alabama at Birmingham · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this clinical trial is to develop an pharmacist-led preoperative opioid taper intervention for patients undergoing total knee or hip replacement who are on chronic opioids before their surgery. The main questions it aims to answer are: * Is the intervention feasible and acceptable to patients? * Does the intervention result in a decrease in opioid dose during the preoperative period? …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * decided to pursue primary, unilateral total knee or hip arthroplasty with planned surgery date in 4-8 weeks * currently taking between 20 and 90 MME of oral opioids, and that dose has been stable for at least 3 months * have a reliable telephone number for contact * speaks Eng…
Contacts

Kevin R Riggs, MD

205-934-0778

kriggs@uabmc.edu

CONTACT

Shakristal Williams

205-934-2304

shakristalwilliams@uabmc.edu

CONTACT